International Clinical Trial: Phase II Clinical Study of Tislelizumab Combined with Albumin-Bound Paclitaxel and Cisplatin/Carboplatin as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132403) titled 'Phase II Clinical Study of Tislelizumab Combined with Albumin-Bound Paclitaxel and Cisplatin/Carboplatin as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma' on Sept. 14.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Peking Union Medical College Hospital

Condition: Patients with locally advanced head and neck squamous cell carcinoma

Intervention: experimental group:1) Not suitable for any type of dual-drug chemotherapy specified in the protocol. 2) Previously received any treatment for head and neck squamous cell carcinoma. 3) Head and neck squamous...